299 results on '"Lanfrancone, Luisa"'
Search Results
2. Caloric restriction leads to druggable LSD1-dependent cancer stem cells expansion
3. Comprehensive genomic profiling on metastatic Melanoma: results from a network screening from 7 Italian Cancer Centres
4. Actionable Genetic Screens Unveil Targeting of AURKA, MEK, and Fatty Acid Metabolism as an Alternative Therapeutic Approach for Advanced Melanoma
5. TFEB and TFE3 drive kidney cystogenesis and tumorigenesis
6. Targeting the MITF/APAF-1 axis as salvage therapy for MAPK inhibitors in resistant melanoma
7. Targeting the USP7/RRM2 axis drives senescence and sensitizes melanoma cells to HDAC/LSD1 inhibitors
8. Epigenetically regulated PCDHB15 impairs aggressiveness of metastatic melanoma cells
9. Structural Insights on the Role of Halogen Bonding in Protein MEK Kinase‐Inhibitor Complexes
10. Transcriptional activation of RagD GTPase controls mTORC1 and promotes cancer growth
11. Structural Insights on the Role of Halogen Bonding in Protein MEK Kinase‐Inhibitor Complexes.
12. Long non-coding RNA TINCR suppresses metastatic melanoma dissemination by preventing ATF4 translation
13. BS148 Reduces the Aggressiveness of Metastatic Melanoma via Sigma-2 Receptor Targeting
14. Abstract 5500: Patient-derived organotypic cultures (PDOCs) from melanoma metastases as a precision medicine test to improve patient management
15. Data from In Vivo Genetic Screens of Patient-Derived Tumors Revealed Unexpected Frailty of the Transformed Phenotype
16. Supplementary Tables S1 - S5 from In Vivo Genetic Screens of Patient-Derived Tumors Revealed Unexpected Frailty of the Transformed Phenotype
17. Supplementary Methods, Figure Legends from In Vivo Genetic Screens of Patient-Derived Tumors Revealed Unexpected Frailty of the Transformed Phenotype
18. Supplementary Figures S1 - S8 from In Vivo Genetic Screens of Patient-Derived Tumors Revealed Unexpected Frailty of the Transformed Phenotype
19. Supplementary Figure 4 from RaLP, a New Member of the Src Homology and Collagen Family, Regulates Cell Migration and Tumor Growth of Metastatic Melanomas
20. Data from RaLP, a New Member of the Src Homology and Collagen Family, Regulates Cell Migration and Tumor Growth of Metastatic Melanomas
21. Supplementary Figure 3 from RaLP, a New Member of the Src Homology and Collagen Family, Regulates Cell Migration and Tumor Growth of Metastatic Melanomas
22. Supplementary Figure 1 from RaLP, a New Member of the Src Homology and Collagen Family, Regulates Cell Migration and Tumor Growth of Metastatic Melanomas
23. Supplementary Figure 2 from RaLP, a New Member of the Src Homology and Collagen Family, Regulates Cell Migration and Tumor Growth of Metastatic Melanomas
24. An X Chromosome-Linked Gene Encoding a Protein with Characteristics of a Rho GAP Predominantly Expressed in Hematopoietic Cells
25. WDR5 inhibition halts metastasis dissemination by repressing the mesenchymal phenotype of breast cancer cells
26. Dual modulation of MCL-1 and mTOR determines the response to sunitinib
27. DNA methylome combined with chromosome cluster-oriented analysis provides an early signature for cutaneous melanoma aggressiveness
28. Author response: DNA methylome combined with chromosome cluster-oriented analysis provides an early signature for cutaneous melanoma aggressiveness
29. Primary ipilimumab/nivolumab followed by adjuvant nivolumab in patients with locally advanced or oligometastatic melanoma: Update on outcome.
30. Pirin Inhibits Cellular Senescence in Melanocytic Cells
31. Regulation of LncRNAs in Melanoma and Their Functional Roles in the Metastatic Process
32. Inhibition of Anchorage-Dependent Cell Spreading Triggers Apoptosis in Cultured Human Endothelial Cells
33. Amplification of the c-myb Oncogene in a Case of Human Acute Myelogenous Leukemia
34. Human Leukemia Cells Synthesize and Secrete Proteins Related to Platelet-Derived Growth Factor
35. The proapoptotic and antimitogenic protein p66SHC acts as a negative regulator of lymphocyte activation and autoimmunity
36. p52Shc is required for CXCR4-dependent signaling and chemotaxis in T cells
37. Cooperation and selectivity of the two Grb2 binding sites of p52Shc in T-cell antigen receptor signaling to Ras family GTPases and Myc-dependent survival
38. Drug Repurposing to Target the Apoptosome in MAPKi-Resistant Melanoma
39. A p53-p66Shc signalling pathway controls intracellular redox status, levels of oxidation-damaged DNA and oxidative stress-induced apoptosis
40. Human endothelial cells expressing polyoma middle T induce tumors
41. Constitutive activation of the Ras/MAP kinase pathway and enhanced TCR signaling by targeting the Shc adaptor to membrane rafts
42. The p66shc adaptor protein controls oxidative stress response and life span in mammals
43. ShcD Binds DOCK4, Promotes Ameboid Motility and Metastasis Dissemination, Predicting Poor Prognosis in Melanoma
44. Abstract A15: New treatment opportunities by in vivo and in vitro screening approaches in melanoma
45. The RIα subunit of protein kinase A (PKA) binds to Grb2 and allows PKA interaction with the activated EGF-Receptor
46. Opposite effects of the p52shc/p46shc and p66shc splicing isoforms on the EGF receptor–MAP kinase–fos signalling pathway
47. Chromosomal localization of four human zinc finger cDNAs
48. Not all Shc' roads leads to Ras
49. An X chromosome-linked gene encoding a protein with characteristics of a rhoGAP predominantly expressed in hematopoietic cells
50. Transformation by polyoma virus middle T-antigen involves the binding and tyrosine phosphorylation of Shc
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.